Amarin Corporation plc (NASDAQ:AMRN) Q1 2023 Earnings Conference Call May 3, 2023 8:00 AM ET

Company Participants

Lisa DeFrancesco - Senior Vice President, Corporate Affairs and Investor Relations

Aaron Berg - Interim President & Chief Executive Officer

Tom Reilly - Chief Financial Officer

Steve Ketchum - President R&D and Chief Scientific Officer

Conference Call Participants

Louise Chen - Cantor

Roanna Ruiz - SVB Securities

Operator

Greetings and welcome to Amarin Corporation's Conference Call to Discuss its First Quarter 2023 Financial Results and Operational Update.

I would now like to turn the conference call over to Lisa DeFrancesco, Senior Vice President, Investor Relations and Corporate Affairs at Amarin.

Lisa DeFrancesco

Good morning, everyone, and thank you for joining us. Please be aware that this conference call will contain forward-looking statements that are intended to be covered under the Safe Harbor provided under federal securities law. We may not achieve our goals, carryout our plans or intentions or meet the expectations disclosed in our forward-looking statements.

Actual results or events could differ materially, so you should not place undue reliance on these statements. We assume no obligation to update these statements as circumstances change. Our forward-looking statements do not reflect the potential impact of significant transactions we may enter into, such as mergers, acquisitions, dispositions, joint ventures or any material agreements that we may enter into, amend or terminate.

For additional information concerning the risk factors that could cause actual results to differ materially, please see the Risk Factor section of our annual report on Form 10-K for the year ended December 31, 2022, and our quarterly report on Form 10-Q for the quarter ended March 31, 2023, which has been filed with the SEC and is available through the Investor Relations section of our website at www.amarincorp.com. We encourage everyone to read these documents. An archive of this call will be posted on Amarin's website in the Investor Relations section.

Now turning to today's agenda, Aaron Berg, Amarin's Interim President & Chief Executive Officer will lead our discussion, and Tom Reilly, Amarin's Chief Financial Officer, will provide a detailed review of our first quarter 2023 financial results. Following prepared remarks, we will open the call to your questions. Steve Ketchum, President R&D and Chief Scientific Officer will also be available for Q&A

I will now turn the call over to Aaron Berg, Interim President and Chief Executive Officer of Amarin. Aaron?